Status:
UNKNOWN
Outcome of Platelet Rich Plasma in ICSI Patients, a Randomized Controlled Trial
Lead Sponsor:
Dr. Osman Hospital
Conditions:
Pregnancy Outcome
Eligibility:
FEMALE
18-35 years
Phase:
PHASE2
Brief Summary
2 groups randomized to PRP injectioninto uterine cavity at mock embryo transfer, and a control group with only mock embryo transfer.
Detailed Description
Participants are allocated in two groups ( randomized). Study is conducted in Dar El Teb infertility and IVF centre, Egypt. Normoresponder patients (9-15 mature follicles on day of HCG administration)...
Eligibility Criteria
Inclusion
- Normoresponder patients (i.e. patients with 9 to 15 mature follicles on the day of HCG administration ) with expected good reproductive outcomes of IVF-ET and candidates for fresh embryo transfer
Exclusion
- Age less than 18 years and more than 35 years Body mass index more than 30kg/m2 Serum progesterone level less than 1.5 ng/ml on the trigger day Smoking Moreover, patients with previous IVF cycle, PCOS ( polycystic ovarian syndrome), pelvic inflammatory disease, endometriosis, uterine anomalies, Ashermann syndrome, chronic endometritis, chromosomal anomalies, increased peripheral NK cells, hereditary thrombophylia and antiphospholipid syndrome were excluded from the study
Key Trial Info
Start Date :
June 15 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
April 15 2021
Estimated Enrollment :
788 Patients enrolled
Trial Details
Trial ID
NCT04434495
Start Date
June 15 2020
End Date
April 15 2021
Last Update
June 17 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.